RGLS RSI Chart
Last 7 days
-9.5%
Last 30 days
-14.5%
Last 90 days
30.7%
Trailing 12 Months
28.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 1.6M | 0 | 0 | 0 |
2023 | 989.0K | 0 | 1.4M | 1.5M |
2022 | 4.1M | 0 | 2.4M | 605.0K |
2021 | 0 | 10.4M | 10.8M | 5.9M |
2020 | 7.6M | 8.4M | 9.2M | 10.0M |
2019 | 2.8M | 4.1M | 5.5M | 6.8M |
2018 | 72.0K | 72.0K | 72.0K | 1.4M |
2017 | 913.5K | 633.0K | 352.5K | 72.0K |
2016 | 15.9M | 11.0M | 6.1M | 1.2M |
2015 | 10.2M | 13.3M | 14.1M | 20.8M |
2014 | 18.0M | 13.9M | 8.9M | 7.7M |
2013 | 12.6M | 14.0M | 17.4M | 19.6M |
2012 | 13.8M | 13.8M | 12.8M | 12.7M |
2011 | 9.9M | 11.2M | 12.5M | 13.8M |
2010 | 0 | 0 | 0 | 8.6M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 14, 2024 | papadopoulos stelios | acquired | 400,000 | 1.6 | 250,000 | - |
Jan 18, 2024 | calsada crispina | sold | -6,510 | 1.1906 | -5,468 | chief financial officer |
Jan 18, 2024 | aker christopher ray | sold | -6,510 | 1.1906 | -5,468 | sr. vp & general counsel |
Jan 18, 2024 | hagan joseph p | sold | -17,358 | 1.1906 | -14,580 | chief executive officer |
Jan 12, 2024 | calsada crispina | acquired | - | - | 11,250 | chief financial officer |
Jan 12, 2024 | aker christopher ray | acquired | - | - | 11,250 | sr. vp & general counsel |
Jan 12, 2024 | hagan joseph p | acquired | - | - | 30,000 | chief executive officer |
Apr 13, 2023 | papadopoulos stelios | acquired | 200,000 | 0.9001 | 222,198 | - |
Mar 01, 2022 | drygin denis | bought | 17,637 | 0.23 | 76,686 | chief scientific officer |
Feb 04, 2022 | drygin denis | bought | 5,362 | 0.23 | 23,314 | chief scientific officer |
Which funds bought or sold RGLS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | Community Bank, N.A. | unchanged | - | 1,104 | 1,980 | -% |
May 15, 2024 | Sarissa Capital Management LP | unchanged | - | 296,293 | 533,327 | 0.09% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 18,794 | 9,228 | 9,250 | -% |
May 15, 2024 | NEA Management Company, LLC | added | 232 | 16,136,900 | 18,627,300 | 1.16% |
May 15, 2024 | Alyeska Investment Group, L.P. | new | - | 2,681,250 | 2,681,250 | 0.02% |
May 15, 2024 | Hudson Bay Capital Management LP | new | - | 1,677,000 | 1,677,000 | 0.01% |
May 15, 2024 | DAFNA Capital Management LLC | reduced | -3.65 | 1,661,040 | 3,083,180 | 0.70% |
May 15, 2024 | PRELUDE CAPITAL MANAGEMENT, LLC | added | 229 | 329,981 | 381,514 | 0.02% |
May 15, 2024 | Polar Asset Management Partners Inc. | new | - | 1,544,830 | 1,544,830 | 0.03% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | new | - | 5,400,650 | 5,400,650 | -% |
Unveiling Regulus Therapeutics Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Regulus Therapeutics Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Regulus Therapeutics Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 24.1% | 438,000 | 353,000 | 438,000 | 415,000 | 333,000 | 187,000 | 114,000 | 41,000 | 1,000 | 821,000 | 5,000,000 | 5,000,000 | 3,339,333 | 1,678,667 | 18,000 | 18,000 | 18,000 | 6,778,000 | 3,398,000 | 18,000 | 18,000 |
Operating Expenses | 6.3% | 8,826,000 | 8,300,000 | 8,125,000 | 7,369,000 | 6,932,000 | 7,563,000 | 6,569,000 | 6,960,500 | 8,419,000 | 6,638,000 | 6,028,000 | 6,095,000 | 6,496,000 | 5,541,000 | 4,453,000 | 5,011,000 | 4,686,000 | 9,516,000 | 8,000,000 | 9,872,000 | 13,362,000 |
S&GA Expenses | -100.0% | - | 2,537,000 | 2,637,000 | 2,444,000 | 2,219,000 | 2,253,000 | 2,890,000 | 2,551,500 | 2,504,000 | 2,488,000 | 2,078,500 | 2,059,000 | 2,254,000 | 2,422,000 | 2,363,000 | 2,571,000 | 2,850,000 | 3,533,000 | 2,745,000 | 2,993,000 | 3,349,000 |
R&D Expenses | 4.8% | 6,040,000 | 5,763,000 | 5,488,000 | 4,925,000 | 4,713,000 | 5,310,000 | 3,679,000 | 4,409,000 | 5,915,000 | 4,150,000 | 3,950,500 | 4,036,000 | 4,242,000 | 3,119,000 | 2,090,000 | 2,440,000 | 1,836,000 | 5,983,000 | 5,255,000 | 6,879,000 | 10,013,000 |
EBITDA Margin | 1.9% | -18.62 | -18.98 | -20.32 | -28.19 | -45.47 | -11.80 | -6.71 | -4.52 | -1.89 | -1.25 | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | -28.9% | 81,000 | 114,000 | 137,000 | 185,000 | 196,000 | 175,000 | 155,000 | 213,500 | 210,000 | 216,000 | 392,000 | 466,000 | 461,000 | 489,000 | 499,000 | 517,000 | 538,000 | 578,000 | 496,000 | 620,000 | 621,000 |
Income Taxes | - | - | - | - | - | - | - | 1,000 | - | - | 1,000 | 7,000 | 1,000 | - | -8,000 | - | - | 1,000 | - | 61,500 | - | - |
Earnings Before Taxes | -5.1% | -8,469,000 | -8,061,000 | -7,824,000 | -7,139,000 | -6,795,000 | -7,551,000 | -6,718,000 | -7,133,000 | -8,628,000 | -6,033,000 | -1,315,000 | -1,523,000 | -6,947,000 | -5,945,000 | -4,893,000 | -5,423,000 | -5,015,000 | -3,260,000 | -8,502,000 | -10,273,000 | -13,847,000 |
EBT Margin | 2.2% | -19.08 | -19.52 | -20.95 | -29.06 | -46.81 | -12.16 | -6.94 | -4.74 | -2.03 | -1.43 | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -5.1% | -8,469,000 | -8,061,000 | -7,824,000 | -7,139,000 | -6,795,000 | -7,551,000 | -6,719,000 | -7,133,000 | -8,628,000 | -6,034,000 | -1,322,000 | -1,524,000 | -6,947,000 | -5,937,000 | -4,893,000 | -5,423,000 | -5,016,000 | -3,260,000 | -8,563,000 | -10,273,000 | -13,847,000 |
Net Income Margin | 2.2% | -19.08 | -19.52 | -20.95 | -29.06 | -46.81 | -12.16 | -6.94 | -4.74 | -2.03 | -1.43 | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | -44.8% | -8,971,000 | -6,196,000 | -6,818,000 | -8,115,000 | -6,316,000 | -6,736,000 | -6,483,000 | -7,872,000 | -5,588,000 | -5,155,000 | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 271.2% | 114 | 31.00 | 38.00 | 44.00 | 37.00 | 47.00 | 52.00 | 54.00 | 61.00 | 68.00 | 43.00 | 50.00 | 40.00 | 38.00 | 27.00 | 30.00 | 35.00 | 42.00 | 21.00 | 26.00 | 20.00 |
Current Assets | 260.0% | 101 | 28.00 | 35.00 | 41.00 | 35.00 | 44.00 | 49.00 | 51.00 | 58.00 | 65.00 | 40.00 | 46.00 | 37.00 | 37.00 | 26.00 | 29.00 | 34.00 | 40.00 | 20.00 | 24.00 | 18.00 |
Cash Equivalents | 24.7% | 30.00 | 24.00 | 26.00 | 37.00 | 30.00 | 24.00 | 20.00 | 35.00 | 54.00 | 60.00 | 36.00 | 41.00 | 32.00 | 31.00 | 18.00 | 23.00 | 28.00 | 34.00 | 15.00 | 20.00 | 10.00 |
Net PPE | 2.4% | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 |
Liabilities | -31.5% | 7.00 | 10.00 | 9.00 | 10.00 | 10.00 | 13.00 | 12.00 | 12.00 | 12.00 | 13.00 | 14.00 | 13.00 | 13.00 | 12.00 | 20.00 | 21.00 | 20.00 | 22.00 | 22.00 | 21.00 | 26.00 |
Current Liabilities | -33.2% | 6.00 | 9.00 | 8.00 | 8.00 | 9.00 | 12.00 | 11.00 | 6.00 | 5.00 | 5.00 | 11.00 | 10.00 | 10.00 | 12.00 | 19.00 | 21.00 | 20.00 | 22.00 | 21.00 | 20.00 | 25.00 |
Long Term Debt | - | - | - | - | - | - | - | - | 3.00 | 4.00 | 5.00 | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | - | - | - | - | - | - | - | - | 3.00 | 4.00 | 5.00 | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | 407.8% | 108 | 21.00 | 28.00 | 34.00 | 27.00 | 33.00 | 40.00 | 42.00 | 49.00 | 55.00 | 29.00 | 37.00 | 27.00 | 26.00 | 8.00 | 9.00 | 15.00 | 20.00 | - | 5.00 | - |
Retained Earnings | -1.7% | -521 | -513 | -505 | -497 | -490 | -483 | -476 | -468 | -461 | -454 | -447 | -439 | -433 | -427 | -425 | -424 | -417 | -411 | -406 | -401 | -395 |
Additional Paid-In Capital | 17.8% | 629 | 534 | 533 | 531 | 517 | 516 | 516 | 511 | 511 | 510 | 477 | 476 | 460 | 453 | 433 | 433 | 432 | 431 | 406 | 406 | 390 |
Shares Outstanding | 223.7% | 65.00 | 20.00 | 20.00 | 19.00 | 17.00 | 17.00 | 15.00 | 15.00 | 15.00 | 15.00 | 8.00 | 7.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 27.00 | - | - | - | 29.00 | - | - | - | 68.00 | - | - | - | 23.00 | - | - | - | 24.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -42.7% | -8,742 | -6,125 | -6,277 | -6,252 | -8,114 | -6,253 | -6,733 | -6,159 | -6,381 | -7,831 | -5,562 | -5,024 | -5,711 | 3,189 | -4,497 | -5,226 | -6,002 | -4,977 | -4,720 | -5,691 | -4,433 |
Share Based Compensation | -4.9% | 985 | 1,036 | 973 | 382 | 410 | 397 | 360 | 420 | 1,000 | 671 | 807 | 754 | 691 | 470 | 692 | 629 | 823 | 472 | 538 | 319 | 959 |
Cashflow From Investing | -1692.5% | -78,544 | 4,932 | -5,440 | - | 14,999 | 10,467 | -12,861 | -12,624 | -102 | -41.00 | -26.00 | -131 | -53.00 | - | -11.00 | - | - | -59.00 | -141 | 113 | 161 |
Cashflow From Financing | 10764.9% | 93,105 | -873 | 287 | 13,207 | -805 | - | 4,489 | - | 2.00 | 32,407 | -4.00 | 14,998 | 6,336 | 10,055 | -1,068 | 593 | -67.00 | 24,511 | -64.00 | 14,829 | 657 |
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 6,040 | $ 4,925 |
General and administrative | 2,786 | 2,444 |
Total operating expenses | 8,826 | 7,369 |
Loss from operations | (8,826) | (7,369) |
Other income (expense): | ||
Interest and other income | 438 | 415 |
Interest and other expense | (81) | (185) |
Loss before income taxes | (8,469) | (7,139) |
Net loss and comprehensive loss | (8,469) | (7,139) |
Other comprehensive loss: | ||
Unrealized (loss) gain on investments, net | (45) | 12 |
Comprehensive loss | $ (8,514) | $ (7,127) |
Net loss per share, basic (in usd per share) | $ (0.29) | $ (0.42) |
Net loss per share, diluted (in usd per share) | $ (0.29) | $ (0.42) |
Weighted average shares used to compute basic net loss per share (in shares) | 28,746,802 | 16,844,243 |
Weighted average shares used to compute diluted net loss per share (in shares) | 28,746,802 | 16,844,243 |
CONDENSED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 29,586 | $ 23,767 |
Short-term investments | 67,968 | 0 |
Restricted cash | 62 | 62 |
Prepaid materials, net | 3,010 | 3,010 |
Prepaid expenses and other current assets | 821 | 1,340 |
Total current assets | 101,447 | 28,179 |
Long-term investments | 10,171 | 0 |
Property and equipment, net | 1,086 | 1,061 |
Intangibles, net | 30 | 33 |
Right of use asset | 1,330 | 1,477 |
Other assets | 74 | 0 |
Total assets | 114,138 | 30,750 |
Current liabilities: | ||
Accounts payable | 406 | 204 |
Accrued liabilities | 604 | 691 |
Accrued research and development expenses | 700 | 921 |
Accrued compensation | 1,185 | 2,979 |
Term loan, less debt issuance costs | 540 | 1,334 |
Other current liabilities | 2,247 | 2,379 |
Total current liabilities | 5,682 | 8,508 |
Lease liability, less current portion | 868 | 1,055 |
Total liabilities | 6,550 | 9,563 |
Commitments and Contingencies | ||
Stockholders’ equity: | ||
Common stock, $0.001 par value; 300,000,000 shares authorized at March 31, 2024 and December 31, 2023; 65,465,251 and 20,222,672 shares issued and outstanding at March 31, 2024 (unaudited) and December 31, 2023, respectively | 65 | 20 |
Additional paid-in capital | 629,245 | 534,375 |
Accumulated other comprehensive loss | (45) | 0 |
Accumulated deficit | (521,682) | (513,213) |
Total stockholders’ equity | 107,588 | 21,187 |
Total liabilities and stockholders’ equity | 114,138 | 30,750 |
Class A-1 Convertible Preferred Stock | ||
Stockholders’ equity: | ||
Convertible preferred stock | 0 | 0 |
Class A-2 Convertible Preferred Stock | ||
Stockholders’ equity: | ||
Convertible preferred stock | 1 | 1 |
Class A-3 Convertible Preferred Stock | ||
Stockholders’ equity: | ||
Convertible preferred stock | 0 | 0 |
Class A-4 Convertible Preferred Stock | ||
Stockholders’ equity: | ||
Convertible preferred stock | 4 | 4 |
Class A-5 Convertible Preferred Stock | ||
Stockholders’ equity: | ||
Convertible preferred stock | 0 | 0 |
Class A-6 Convertible Preferred Stock | ||
Stockholders’ equity: | ||
Convertible preferred stock | $ 0 | $ 0 |